Provides outsourced OEM manufacturing and private-label services to other companies, and sells herbal health, diet and vitamin supplements.
10-K for FY2025, filed Mar 27, 2026
OEM customers pay for outsourced manufacturing services when the manufacturing work is complete and the finished goods are delivered.
10-K for FY2025, filed Mar 27, 2026
10-K for FY2025, filed Mar 27, 2026
FY2025 revenue by product or service ↗$1.9M
10-K for FY2025, filed Mar 27, 2026
$1.9M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Revenue from OEM services
Sold outright
10-K for FY2025, filed Mar 27, 2026 |
100% |
Revenue from OEM services, FY2025
$1.9M Sources
|
Sold outright |
|
Shipping and delivery Income
|
0.1% |
Shipping and delivery Income, FY2025
$1.2K Sources
|
Other companies buy OEM and private-label services; Bio Essence also sells health supplements.
10-K for FY2025, filed Mar 27, 2026
10-K for FY2025, filed Mar 27, 2026
For the year ended December 31, 2025, the Company had four major customers accounted for 21.6%, 12.7%, 10.1% and 10.0%, respectively, of…View ↗
Yes. It kept 47 cents of every revenue dollar as net income in FY2025.
10-K for FY2025, filed Mar 27, 2026
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
8-K, filed Apr 24, 2026
On April 20, 2026, Bio Essence Corp., a California corporation (“Company”) entered into a Asset Purchase Agreement (“APA”) with Zhituo…View ↗
Growing. Revenue grew 2.1x in 4 years, from $888K in FY2021 to $1.9M in FY2025, about 21% a year.
Operations and manufacturing
The older report described subsidiary operations producing products and providing OEM and private-label services; the latest says operations run through the company itself and manufacturing is outsourced after the sale of BEP.
10-K for FY2022, filed Mar 30, 2023 10-K for FY2025, filed Mar 27, 2026The primary focus of BEP was producing products for BEH and McBE, along with providing original equipment manufacturing and private label…View ↗
Pharmaceutical development
The older report said McBE was pursuing pharmaceutical development; the latest report says McBE was dissolved.
10-K for FY2022, filed Mar 30, 2023 10-K for FY2025, filed Mar 27, 2026The primary focus of BEH is producing products for BEE and McBE, along with providing original equipment manufacturing and private label…View ↗
The primary focus of BEP was producing products for BEH and McBE, along with providing original equipment manufacturing and private label…View ↗
Loading...